240 related articles for article (PubMed ID: 27162244)
1. FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.
Weng W; Okugawa Y; Toden S; Toiyama Y; Kusunoki M; Goel A
Clin Cancer Res; 2016 Oct; 22(19):4947-4957. PubMed ID: 27162244
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
Wang Y; Wu M; Lei Z; Huang M; Li Z; Wang L; Cao Q; Han D; Chang Y; Chen Y; Liu X; Xue L; Mao X; Geng J; Chen Y; Dai T; Ren L; Wang Q; Yu H; Chen C; Chu X
J Exp Clin Cancer Res; 2018 Nov; 37(1):292. PubMed ID: 30486864
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1.
Xu K; Liu X; Mao X; Xue L; Wang R; Chen L; Chu X
Cell Physiol Biochem; 2015; 35(2):499-515. PubMed ID: 25613903
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
6. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
8. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
9. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
[No Abstract] [Full Text] [Related]
10. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
[TBL] [Abstract][Full Text] [Related]
11. microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.
Sun M; Wang X; Tu C; Wang S; Qu J; Xiao S
Cell Biol Int; 2017 Dec; 41(12):1272-1282. PubMed ID: 28225180
[TBL] [Abstract][Full Text] [Related]
12. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.
Kaneda H; Arao T; Tanaka K; Tamura D; Aomatsu K; Kudo K; Sakai K; De Velasco MA; Matsumoto K; Fujita Y; Yamada Y; Tsurutani J; Okamoto I; Nakagawa K; Nishio K
Cancer Res; 2010 Mar; 70(5):2053-63. PubMed ID: 20145154
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
14. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
15. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
17. Gas1 Inhibits Metastatic and Metabolic Phenotypes in Colorectal Carcinoma.
Li Q; Qin Y; Wei P; Lian P; Li Y; Xu Y; Li X; Li D; Cai S
Mol Cancer Res; 2016 Sep; 14(9):830-40. PubMed ID: 27401611
[TBL] [Abstract][Full Text] [Related]
18. MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
Wang Y; Zeng J; Pan J; Geng X; Li L; Wu J; Song P; Wang Y; Liu J; Wang L
Oncotarget; 2016 May; 7(20):29275-86. PubMed ID: 27086911
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.
Weng W; Wei Q; Toden S; Yoshida K; Nagasaka T; Fujiwara T; Cai S; Qin H; Ma Y; Goel A
Clin Cancer Res; 2017 Jul; 23(14):3918-3928. PubMed ID: 28174233
[No Abstract] [Full Text] [Related]
20. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]